Science Explorer Back to mapMap
Discussion
Company · Kongens Lyngby · Denmark

AntibioTx (Denmark)

Research works
4
▼ 100% vs 2018-21
Citations
150
36.4 per fractional work
Top-10% rate
13.1%
all institutions 10.0%
Open access
51%
world 40%
International
76%
world 18%

Not ranked overall: AntibioTx (Denmark) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does AntibioTx (Denmark) work in?

In all years, 60% of research at AntibioTx (Denmark) is in Life Sciences, 33% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (44%), Medicine (26%), Immunology and Microbiology (9%). It does 1.5× the world's share of Life Sciences.

Life Sciences60%Physical Sciences5%Health Sciences33%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology244.2%
    2. Immunology and Microbiology09.3%
    3. Agricultural and Biological Sciences04.7%
    4. Pharmacology, Toxicology and Pharmaceutics02.3%
    1. Medicine125.6%
    2. Health Professions04.7%
    3. Veterinary02.3%
    1. Chemistry04.7%
    1. Business, Management and Accounting02.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    What are the most cited papers from AntibioTx (Denmark)?

    The most cited paper from AntibioTx (Denmark) is "Prediction of antibiotic resistance: time for a new preclinical paradigm?" (Morten Otto Alexander Sommer, Christian Munck, Rasmus Vendler Toft-Kehler et al., 2017), with 319 citations. Next come "Antibiotics that specifically block translation in virus-infected cells." (40) and "Cyclization of phenylacetyl-L-cysteinyl-D-valine to benzylpenicillin using cell-free extracts of Streptomyces clavuligerus." (6).

    Most cited papers
    #PaperReleasedCitations
    1 Prediction of antibiotic resistance: time for a new preclinical paradigm? Morten Otto Alexander Sommer, Christian Munck, Rasmus Vendler Toft-Kehler et al. · Nature Reviews Microbiology ReviewOpen access 31 Jul 2017 319
    2 Antibiotics that specifically block translation in virus-infected cells. Juan Carlos Lacal, David Vázquez, Jose M Fernandez-Sousa et al. · The Journal of Antibiotics Open access 1980 40
    3 Cyclization of phenylacetyl-L-cysteinyl-D-valine to benzylpenicillin using cell-free extracts of Streptomyces clavuligerus. José Marı́a Luengo, Manuel J. López-Nieto, Francisco Salto · The Journal of Antibiotics Open access 1986 6
    4 Antibiorésistance à l’échelle « Une seule santé » : stratégies, enjeux et opportunités Yohann Lacotte, Marie-Cécile Ploy · Bulletin de l Académie vétérinaire de France Open access 2021 1
    All 4 most cited papers, with filters and sorting

    Which research topics does AntibioTx (Denmark) publish most on?

    By volume: Advanced Biosensing Techniques and Applications, Gene expression and cancer classification, Genomic variations and chromosomal abnormalities and Microbial Natural Products and Biosynthesis.

    1. 1 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
    2. 2 Gene expression and cancer classification Molecular Biology 0 works
    3. 3 Genomic variations and chromosomal abnormalities Genetics 0 works
    4. 4 Microbial Natural Products and Biosynthesis Pharmacology 0 works
    5. 5 Bacterial Genetics and Biotechnology Genetics 0 works
    6. 6 Fungal and yeast genetics research Molecular Biology 0 works
    7. 7 Health and Lifestyle Studies General Health Professions 0 works
    8. 8 Biochemical and Molecular Research Molecular Biology 0 works
    9. 9 Viral Infections and Immunology Research Cardiology and Cardiovascular Medicine 0 works
    10. 10 Fungal Biology and Applications Pharmacology 0 works

    How open and international is its research?

    Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available51.4%not open48.6%

    World: 40% of research is openly available.

    with international co-authors75.7%domestic only24.3%

    World: 18% is written across borders.

    How has AntibioTx (Denmark)'s research output changed?

    Output in 2022-2025 was 100% lower than in 2018-2021.

    1990200020102020
    grewheldshrank

    The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

    Its share of all research

    Growing output can still be a shrinking share: all of science grows. This is AntibioTx (Denmark) as a percentage of every work published that year, 0.0000056% in 2019.

    0.000050%0.00010%AntibioTx (Denmark)0.0000039% in 20211990200020102020

    Fractional works of AntibioTx (Denmark) over all fractional works that year. How the balance of science has shifted.

    Other research institutions in Kongens Lyngby

    All research institutions in Kongens Lyngby

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

    Discussion

    Ask a question or share a note about AntibioTx (Denmark). Posts are plain text and can be reported.